Anti-India patent law US congressional letter

170 Members of Congress have sent a letter to US President Obama citing concerns over growing trade imbalance between US and India accruing it to the policy changes and court decision favoring domestic pharma industry over MNCs.

In the letter, Congress members highlighted that  actions by Indian Government like issuance of Compulsory License for a pharmaceutical drugs greatly concern them as this is having negative impact on innovation and IP which are the driving forces behind US economic growth.

Read the letter here


This entry was posted in Compulsory Licensing, Innovation, IP Rights, Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s